Antibiotic resistance: how it arises, the current position and strategies for the future

Christine Perry1, Carly Hall

  • 1University Hospitals Bristol NHS Foundation Trust.

Nursing Times
|October 20, 2009
PubMed

Insights

Antibiotic resistance is rising in Gram-positive and Gram-negative bacteria, making infections untreatable. New antibiotic development is lacking, necessitating urgent strategies to combat this growing public health threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic resistance poses a significant global health threat, with increasing rates in both Gram-positive and Gram-negative bacteria.
  • The rise of antibiotic-resistant bacteria leads to challenging community and healthcare-associated infections.
  • A critical gap exists in the development of new antibiotics, especially for Gram-negative pathogens.

Purpose of the Study:

  • To review the current landscape of antibiotic resistance.
  • To examine the challenges in treating infections caused by resistant bacteria.
  • To explore future strategies for combating bacterial resistance.

Main Methods:

  • Literature review of current antibiotic resistance trends.
  • Analysis of challenges in treatment and management of resistant infections.
  • Exploration of novel antibiotic development pipelines and strategies.

Main Results:

  • Antibiotic resistance is a growing reality, impacting both Gram-positive and Gram-negative bacteria.
  • Both community and healthcare settings face challenges due to antibiotic-resistant infections.
  • There is a concerning lack of new antibiotic development, particularly for Gram-negative bacteria.

Conclusions:

  • The increasing threat of untreatable infections requires immediate attention.
  • Novel strategies are crucial to address the escalating issue of bacterial resistance.
  • Accelerated development of new antibiotics is essential to combat this public health crisis.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...